Search for: "Eli Lilly And Company"
Results 161 - 180
of 1,165
Sort by Relevance
|
Sort by Date
18 Oct 2018, 9:59 pm
Eli Lilly and Company v. [read post]
17 Oct 2018, 8:16 am
Minnesota Attorney General Lori Swanson filed a lawsuit Tuesday in the US District Court for the District of New Jersey alleging insulin manufacturers Sanofi-Aventis US, Novo Nordisk and Eli Lilly deceptively raised insulin prices. [read post]
15 Oct 2018, 1:48 pm
The two companies signed a confidentiality agreement on November 21, 2012. [read post]
10 Sep 2018, 1:25 am
In response to the revocation of two Canadian patents concerning the compounds olanzapine and atomoxetine by Canadian courts, the US pharmaceutical company Eli Lilly initiated arbitral proceedings against Canada on the basis of the investment chapter of the North American Free Trade Agreement (NAFTA). [read post]
10 Sep 2018, 1:20 am
In response to the revocation of two Canadian patents concerning the compounds olanzapine and atomoxetine by Canadian courts, the US pharmaceutical company Eli Lilly initiated arbitral proceedings against Canada on the basis of the investment chapter of the North American Free Trade Agreement (NAFTA). [read post]
9 Sep 2018, 4:18 pm
Doctors in the United States can prescribe HGH from a manufacturer such as Eli Lilly, Novo-Nordisk, Upjohn, Pfizer, Sandoz, Merck, and others. [read post]
10 Aug 2018, 5:51 am
Eli Lilly has decided to just spike the price on insulin with no warning anyway. [read post]
7 Aug 2018, 10:05 pm
Prior to this change, advice provided by foreign practitioners was not protected by patent attorney privilege (Eli Lilly & Company v Pfizer Ireland Pharmaceuticals (No 2) [2004] FCA 850: ‘The language of s 200(2) is clear. [read post]
3 Aug 2018, 8:22 am
Highlights this week include a one-year-on perspective of Actavis v Eli Lilly, further news on the progress of the DSM Directive and an update on the governance issues of the Collecting Society of Nigeria (COSON).PatentsThe Kluwer Patent Blog marks the first year anniversary of the landmark Supreme Court decision Actavis v Eli Lilly: Actavis and Equivalents – One Year On. [read post]
1 Aug 2018, 6:40 am
Whereas the Eli Lilly v. [read post]
5 Jul 2018, 7:20 am
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana filed suit in the Southern District of Indiana alleging that Defendants, Dr. [read post]
5 Jul 2018, 7:20 am
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana filed suit in the Southern District of Indiana alleging that Defendants, Dr. [read post]
Seventh Circuit Upholds Preliminary Injunction Issued in Favor of Elanco US, Inc. Against Arla Foods
21 Jun 2018, 8:02 am
Eli Lilly & Company and its subsidiary, Elanco US Inc., both of Greenfield, Indiana, filed suit in the Eastern District of Wisconsin alleging that Arla Foods, Inc. [read post]
21 Jun 2018, 8:02 am
Eli Lilly & Company and its subsidiary, Elanco US Inc., both of Greenfield, Indiana, filed suit in the Eastern District of Wisconsin alleging that Arla Foods, Inc. [read post]
31 May 2018, 6:25 am
Pharmaceutical maker “Eli Lilly, referring to two popular antidepressants, said in a statement the company ‘remains committed to Prozac [fluoxetine] and Cymbalta [duloxetine] and their safety and benefits, which have been repeatedly affirmed by the US Food and Drug Administration. [read post]
18 May 2018, 5:25 am
Eli Lilly& Co., 598 F.3d 1336, 1351 (Fed. [read post]
17 May 2018, 1:36 pm
Having presided over major decisions impacting both on IP law and practice, not the least Actavis v Eli Lilly, Baron Neuberger will be sharing his insights and reflections on “IP in the UK and Europe – a view from the top”. [read post]
14 May 2018, 12:30 pm
Birss would not be drawn on his views of the Supreme Court's decision in Eli Lilly v Actavis (see the IPKat here - the 109 comments on the post is a good indication of how controversial this decision has been). [read post]
16 Mar 2018, 12:00 am
Eli Lilly argued the proposal may be excluded from the company’s proxy materials under Rule 14a-8(i)(10). [read post]
8 Mar 2018, 6:48 am
Following Actavis vs Eli Lilly, is the UK becoming more author-centric? [read post]
